GLONGHUI, May 15 | Eli Lilly said it has reached a settlement agreement with a medical spa agency that sold products counterfeit its popular diabetes drug Mounjaro and weight loss treatment Zepbound. As part of the agreement, Totality Medispa will make a payment to Eli Lilly and will no longer use the Eli Lilly brand to promote any of its products. Earlier, Eli Lilly and Novo Nordisk sued several medical spas and compound pharmacies to stop selling products claiming to contain active ingredients from commonly used diet pills from these two pharmaceutical companies. Eli Lilly said in a statement that we strongly support actions by state and federal regulators to stop and punish compound pharmacies and other counterfeiters who put patients at risk by selling products that claim to be unsafe for zippert.
礼来与销售Mounjaro和Zepbound仿冒品的水疗中心达成和解
Lilly Settles with Spa Selling Counterfeit Mounjaro and Zepbound Products
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.